Literature DB >> 18475458

Complement activated granulocytes can cause autologous tissue destruction in man.

E Löhde1, H Raude, M Lück, E Kraas, W Lierse.   

Abstract

Activation of polymorphonuclear granulocytes (PMNs) by C5a is thought to be important in the pathogenesis of multiple organ failure during sepsis and after trauma. In our experiment exposure of human PMNs to autologous zymosan activated plasma (ZAP) leads to a rapid increase in chemiluminescence. Heating the ZAP at 56( degrees )C for 30 min did not alter the changes, while untreated plasma induced only baseline activity. The respiratory burst could be completely abolished by decomplementation and preincubation with rabbit antihuman C5a antibodies. Observation of human omentum using electron microscopy showed intravascular aggregation of PMNs, with capillary thrombosis and diapedesis of the cells through endothelial junctions 90 s after exposure to ZAP. PMNs caused disruption of connections between the mesothelial cells. After 4 min the mesothelium was completely destroyed, and connective tissue and fat cells exposed. Native plasma and minimum essential medium did not induce any morphological changes. These data support the concept that C5a activated PMNs can cause endothelial and mesothelial damage in man. Even though a causal relationship between anaphylatoxins and organ failure cannot be proved by these experiments C5a seems to be an important mediator in the pathogenesis of changes induced by severe sepsis and trauma in man.

Entities:  

Year:  1992        PMID: 18475458      PMCID: PMC2365343          DOI: 10.1155/S0962935192000279

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  13 in total

1.  Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.

Authors:  T Sacks; C F Moldow; P R Craddock; T K Bowers; H S Jacob
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

2.  Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.

Authors:  P R Craddock; D Hammerschmidt; J G White; A P Dalmosso; H S Jacob
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

3.  Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value.

Authors:  D E Hammerschmidt; L J Weaver; L D Hudson; P R Craddock; H S Jacob
Journal:  Lancet       Date:  1980-05-03       Impact factor: 79.321

Review 4.  The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.

Authors:  T E Hugli
Journal:  Crit Rev Immunol       Date:  1981-02       Impact factor: 2.214

5.  Role of complement and granulocytes in septic shock.

Authors:  H S Jacob
Journal:  Acta Chir Scand Suppl       Date:  1980

6.  Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis.

Authors:  I M Goldstein; D Roos; H B Kaplan; G Weissmann
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

7.  Metabolism of peripheral nerve myelin in experimental diabetes.

Authors:  N Spritz; H Singh; B Marinan
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

8.  Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites.

Authors:  G O Till; K J Johnson; R Kunkel; P A Ward
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

9.  Human C5a and C5a analogs as probes of the neutrophil C5a receptor.

Authors:  D E Chenoweth; T E Hugli
Journal:  Mol Immunol       Date:  1980-02       Impact factor: 4.407

10.  Role of cell surface contact in the kinetics of superoxide production by granulocytes.

Authors:  C A Dahinden; J Fehr; T E Hugli
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

View more
  4 in total

Review 1.  Impact of thrombosis on pulmonary endothelial injury and repair following sepsis.

Authors:  Colin E Evans; You-Yang Zhao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-01-27       Impact factor: 5.464

2.  Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67.

Authors:  Abdulraman M Alshammari; D David Smith; Jake Parriott; Jason P Stewart; Stephen M Curran; Russell J McCulloh; Peter A Barry; Smita S Iyer; Nicholas Palermo; Joy A Phillips; Yuxiang Dong; Donald R Ronning; Jonathan L Vennerstrom; Sam D Sanderson; Joseph A Vetro
Journal:  ACS Infect Dis       Date:  2020-04-13       Impact factor: 5.084

Review 3.  Complement After Trauma: Suturing Innate and Adaptive Immunity.

Authors:  Shinjini Chakraborty; Ebru Karasu; Markus Huber-Lang
Journal:  Front Immunol       Date:  2018-09-24       Impact factor: 7.561

Review 4.  Immunoinflammatory response in critically ill patients: severe sepsis and/or trauma.

Authors:  Maja Surbatovic; Milic Veljovic; Jasna Jevdjic; Nada Popovic; Dragan Djordjevic; Sonja Radakovic
Journal:  Mediators Inflamm       Date:  2013-11-24       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.